Treatment for genetic diseases.
Robin
Nathaniel H
NH
Department of Genetics, University of Alabama at Birmingham, Kaul Human Genetics Building, Room 210, 1530 3rd Av. South, Birmingham, AL 35294-0024, USA. nrobin@uab.edu
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000818:Animals; D005600:Fragile X Syndrome / Q000188:drug therapy; D030342:Genetic Diseases, Inborn / Q000188:drug therapy*; D020022:Genetic Predisposition to Disease; D036281:Genetic Research; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D019808:Losartan / Q000627:therapeutic use; D008382:Marfan Syndrome / Q000188:drug therapy / Q000235:genetics; D051379:Mice; D017253:Neurofibromatoses / Q000188:drug therapy; D020123:Sirolimus / Q000627:therapeutic use
D047228:Angiotensin II Type 1 Receptor Blockers; D007166:Immunosuppressive Agents; D019808:Losartan; D020123:Sirolimus